Skip to Main Content

Author Details

Alexander J Lazar
The University of Texas MD Anderson Cancer Center
1989
463
92
PMIDPaper TitleJournal TitlePublished Year
37558578Erratum to "Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project": [Annals of Oncology 32 (2021) 1626-1636].Ann Oncol2024
36085392Re-excision After Unplanned Excision of Soft Tissue Sarcoma is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease.Ann Surg Oncol2023
37593416Complete loss of <i>TP53</i> and <i>RB1</i> is associated with complex genome and low immune infiltrate in pleomorphic rhabdomyosarcoma.HGG Adv2023
37747813Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes.Clin Cancer Res2023
37643131The Landscape of Alterations from 1407 Ultra-Rare Sarcomas from the AACR GENIE Database: Clinical Implications.Clin Cancer Res2023
37724990Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome.Clin Cancer Res2023
37058010Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101).Clin Cancer Res2023
37248301Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance.Nat Med2023
37046760Targeting the Molecular and Immunologic Features of Leiomyosarcoma.Cancers (Basel)2023
37414216Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia.Ann Oncol2023
37468627Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells.Nature2023
37468552Correction: "The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms" Leukemia. 2022 Jul;36(7):1720-1748.Leukemia2023
37400233Telomerase reverse transcriptase immunohistochemical expression is sensitive but not specific for TERT gene amplification in acral melanoma.J Cutan Pathol2023
36820825Microparticle-Delivered Cxcl9 Prolongs Braf Inhibitor Efficacy in Melanoma.Cancer Immunol Res2023
36788021Oesophageal glomus tumours: rare neoplasms with aggressive clinical behaviour.Histopathology2023
36845725Case report: Responses to the combination of gemcitabine with sirolimus in two patients with <i>TSC</i>-mutated sarcomas.Front Oncol2023
36871660Multiplatform Analysis of Intratumoral PTEN Heterogeneity in Melanoma.J Invest Dermatol2023
36603130Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time.Cancer Res2023
36630138Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions: A Consensus Statement.JAMA Netw Open2023
36627494Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.Nature2023
36074249Superficial low-grade fibromyxoid sarcoma.J Cutan Pathol2023
36245056ASO Visual Abstract: Re-Excision After Unplanned Excision of Soft Tissue Sarcoma Is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease.Ann Surg Oncol2023
36308008Radiotherapy reimagined: Integrating nanomedicines into radiotherapy clinical trials.Wiley Interdiscip Rev Nanomed Nanobiotechnol2023
36307665Sentinel Lymph Node Biopsy for Extremity and Truncal Soft Tissue Sarcomas: A Systematic Review of the Literature.Ann Surg Oncol2023
36166093Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma.Clin Cancer Res2023
36323987ASO Visual Abstract: Sentinel Lymph Node Biopsy for Extremity and Truncal Soft Tissue Sarcomas-A Systematic Review of the Literature.Ann Surg Oncol2023
34536035Appropriate use criteria for ancillary diagnostic testing in dermatopathology: New recommendations for 11 tests and 220 clinical scenarios from the American Society of Dermatopathology Appropriate Use Criteria Committee.J Cutan Pathol2022
35650195The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma.Nat Commun2022
35583270Pigmented PRRX1::NCOA1-rearranged fibroblastic tumor: A rare morphologic variant of an emerging mesenchymal tumor.J Cutan Pathol2022
35379887Multi-site desmoplastic small round cell tumors are genetically related and immune-cold.NPJ Precis Oncol2022
35705814Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.Nature2022
35705558Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma.Nat Commun2022
35732829The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.Leukemia2022
35537412Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity.Cancer Cell2022
35792683Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study.Cancer2022
35390276The FUS::DDIT3 fusion oncoprotein inhibits BAF complex targeting and activity in myxoid liposarcoma.Mol Cell2022
35850363Final Safety and Health-Related Quality of LIfe Results of the Phase 2/3 Act.In.Sarc Study With Preoperative NBTXR3 Plus Radiation Therapy Versus Radiation Therapy in Locally Advanced Soft-Tissue Sarcoma.Int J Radiat Oncol Biol Phys2022
35810190Multi-modal molecular programs regulate melanoma cell state.Nat Commun2022
36248987Prognostic molecular biomarkers in chordomas: A systematic review and identification of clinically usable biomarker panels.Front Oncol2022
36313661The immune landscape of undifferentiated pleomorphic sarcoma.Front Oncol2022
36371179Challenges associated with the integration of immuno-oncology agents in clinical practice.BMC Med Educ2022
36138151Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome.Nat Med2022
35934010Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial.Lancet Oncol2022
36162599Frequent TRPS1 expression in synovial sarcoma is associated with SS18-SSX fusion oncoprotein activity.Hum Pathol2022
35944500Human and machine: Better at pathology together?Cancer Cell2022
35943386Immune Checkpoint Inhibitors Have Clinical Activity in Patients With Recurrent Chordoma.J Immunother2022
35045964Correction: SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma.Clin Cancer Res2022
34921008A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era.Cancer Discov2022
35128664Real-world use of palbociclib monotherapy in retroperitoneal liposarcomas at a large volume sarcoma center.Int J Cancer2022
35284040Correlation of nuclear pIGF-1R/IGF-1R and YAP/TAZ in a tissue microarray with outcomes in osteosarcoma patients.Oncotarget2022
  • 1 - 50 of 463

Recommended Authors

Dipti P Sajed
David Geffen School of Medicine University of California Los Angeles California USA.
Career Start Year 2016
Number of shared co-authors 2
Yun-Shao Sung
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 11
Lei Zhang
Guangzhou Kingmed Center for Clinical Laboratory
Career Start Year 2009
Number of shared co-authors 21
Malak Abedalthagafi
Emory School of Medicine
Career Start Year 2008
Number of shared co-authors 11
Shaham Beg
New York-Presbyterian Hospital-Weill Cornell Medical College
Career Start Year 2008
Number of shared co-authors 4
Cristiane M Ida
Mayo Clinic Foundation
Career Start Year 2007
Number of shared co-authors 12
Thomas G P Gr??newald
German Cancer Research Center
Career Start Year 2006
Number of shared co-authors 14
Joaquin J Garcia
Mayo Clinic
Career Start Year 2006
Number of shared co-authors 13
Christian F Meyer
Johns Hopkins University School of Medicine
Career Start Year 2005
Number of shared co-authors 14
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 28
Raghwa Sharma
Westmead Hospital
Career Start Year 2004
Number of shared co-authors 4
Simion I Chiosea
University of Pittsburgh
Career Start Year 2003
Number of shared co-authors 20
Juan Miguel Mosquera
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2002
Number of shared co-authors 21
Ga??lle Pierron
Institut Curie Hospital
Career Start Year 2001
Number of shared co-authors 6
Timo Gaiser
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 1
Abbas Agaimy
Institute of Pathology, Friedrich-Alexander University Erlangen-Nurnberg (FAU)
Career Start Year 2000
Number of shared co-authors 25
Paul Fr??neaux
Institut Curie
Career Start Year 1999
Number of shared co-authors 3
Jaime Ferrer
Health Research Institute Hospital La Fe
Career Start Year 1999
Number of shared co-authors 8
Angela C Hirbe
Washington University School of Medicine and Siteman Cancer Center
Career Start Year 1999
Number of shared co-authors 13
Bret Wehrli
Schulich School of Medicine & Dentistry, Western University
Career Start Year 1998
Number of shared co-authors 7
Travis J Hollmann
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 19
Franck Tirode
Cancer Center of Lyon
Career Start Year 1997
Number of shared co-authors 9
Atiya Mansoor
Oregon Health & Science University
Career Start Year 1996
Number of shared co-authors 3
Sarah M Dry
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 1992
Number of shared co-authors 14
Enrique de Alava
Servicio de Anatomia Patologica. Hospital Universitario Virgen del Rocio.
Career Start Year 1992
Number of shared co-authors 21
Simone Hettmer
University Medical Center Freiburg, University of Freiburg
Career Start Year 1990
Number of shared co-authors 7
Scott D Nelson
University of California-Los Angeles
Career Start Year 1990
Number of shared co-authors 4
Juan P Palazzo
Thomas Jefferson University Hospital
Career Start Year 1988
Number of shared co-authors 12
Pedram Argani
The Johns Hopkins Hospital
Career Start Year 1987
Number of shared co-authors 17
Rex C Bentley
Duke School of Medicine
Career Start Year 1984
Number of shared co-authors 9

Collaborators

Raphael E Pollock
James Cancer Center, The Ohio State University
Co-authored papers 73
Michael A Davies
The University of Texas MD Anderson Cancer Center
Co-authored papers 54
Jennifer A Wargo
Co-authored papers 41
Jeffrey E Gershenwald
The University of Texas MD Anderson Cancer Center
Co-authored papers 37
Kelly K Hunt
The University of Texas MD Anderson Cancer Center
Co-authored papers 29
Elizabeth G Demicco
Mount Sinai Hospital and Laboratory Medicine and Pathobiology, University of Toronto
Co-authored papers 28
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Co-authored papers 28
Jonathan C Trent
Sylvester Comprehensive Cancer Center, University of Miami
Co-authored papers 26
Jason L Hornick
Brigham and Women's Hospital and Harvard Medical School
Co-authored papers 23
Hussein A Tawbi
MD Anderson Cancer Center
Co-authored papers 20
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 17
Joseph A Ludwig
The University of Texas MD Anderson Cancer Center
Co-authored papers 17
Janice N Cormier
Co-authored papers 17
Brian P Rubin
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic
Co-authored papers 16
Chad J Creighton
Co-authored papers 14
Mark J Routbort
University of Texas MD Anderson Cancer Center
Co-authored papers 13
Andrew D Cherniack
Dana-Farber Cancer Institute
Co-authored papers 12
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Co-authored papers 11
Linghua Wang
The University of Texas M. D. Anderson
Co-authored papers 11
Najat C Daw
The University of Texas MD Anderson Cancer Center
Co-authored papers 11
Ian E McCutcheon
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 10
Lawrence N Kwong
The University of Texas MD Anderson Cancer Center
Co-authored papers 10
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Co-authored papers 9
Jianhua Hu
Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences
Co-authored papers 9
Georgina V Long
Co-authored papers 9
Richard A Scolyer
Co-authored papers 8
Ken Chen
University of Texas MD Anderson Cancer Center
Co-authored papers 8
Xingzhi Song
The University of Texas MD Anderson Cancer Center
Co-authored papers 7
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 7
Kenneth Aldape
National Cancer Institute
Co-authored papers 7
Release 1.2